litlas
Log inCreate account

Robert K. Hills

Active 1985–2025

Also published as
Robert K Hills
102
Papers
23,754
Citations
78
h-index
100
i10-index

Citations

Citations per year for Robert K. Hills1958: 1 citations1986: 1 citations1991: 2 citations1992: 2 citations1993: 1 citations1995: 1 citations1998: 1 citations1999: 2 citations2000: 1 citations2001: 12 citations2002: 12 citations2003: 9 citations2004: 15 citations2005: 21 citations2006: 44 citations2007: 63 citations2008: 76 citations2009: 107 citations2010: 152 citations2011: 171 citations2012: 186 citations2013: 205 citations2014: 227 citations2015: 224 citations2016: 293 citations2017: 257 citations2018: 249 citations2019: 926 citations2020: 891 citations2021: 877 citations2022: 572 citations2023: 503 citations2024: 805 citations2025: 370 citations2026: 3 citations1959–1985: no citations, so these years are not shown1987–1990: no citations, so these years are not shown1994: no citations, so this year is not shown1996–1997: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,082 citing papers, 22.6% of this breakdownUnited Kingdom: 802 citing papers, 8.7% of this breakdownGermany: 756 citing papers, 8.2% of this breakdownChina: 606 citing papers, 6.6% of this breakdownItaly: 568 citing papers, 6.2% of this breakdownFrance: 463 citing papers, 5% of this breakdownNetherlands: 354 citing papers, 3.8% of this breakdownSpain: 316 citing papers, 3.4% of this breakdownCanada: 279 citing papers, 3% of this breakdownAustralia: 274 citing papers, 3% of this breakdownSwitzerland: 207 citing papers, 2.3% of this breakdownJapan: 187 citing papers, 2% of this breakdown
0%22.6%Other 25.2%

Institutions

Fields

  • Medicine75.8%
  • Biochemistry, Genetics and Molecular Biology17.7%
  • Immunology and Microbiology3.6%
  • Neuroscience0.9%
  • Computer Science0.5%
  • Engineering0.3%
  • Other1.2%

Topics

  • Acute Myeloid Leukemia Research16.6%
  • Acute Lymphoblastic Leukemia research4.6%
  • Hematopoietic Stem Cell Transplantation4%
  • Myeloproliferative Neoplasms: Diagnosis and Treatment3.1%
  • Chronic Myeloid Leukemia Treatments3%
  • Histone Deacetylase Inhibitors Research2.7%
  • Other66%

Coauthors

All papers

Open in search
  1. Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party

    Authors: Gerrit Jan Schuurhuis, Michael Heuser, Sylvie Freeman, Marie C. Béné, Francesco Buccisano, Jacqueline Cloos, David Grimwade, Torsten Haferlach, Robert K. Hills, Christopher S. Hourigan, Jeffrey L. Jorgensen, Wolfgang Kern, Francis Lacombe, Luca Maurillo, Claude Preudhomme, Bert A. van der Reijden, Christian Thiede, Adriano Venditti, Paresh Vyas, Brent L. Wood, Roland B. Walter, Konstanze Döhner, Gail J. Roboz, Gert J. Ossenkoppele - Blood 2018 cited by 1,029

  2. Assessment of Minimal Residual Disease in Standard-Risk AML

    Authors: Adam Ivey, Robert K. Hills, Michael A. Simpson, Jelena Jovanović, Amanda Gilkes, Angela Grech, Yashma Patel, Neesa Bhudia, Hassan Farah, Joanne Mason, Kerry Wall, Susanna Akiki, Mike Griffiths, Ellen Solomon, Frank McCaughan, David C. Linch, Rosemary E. Gale, Paresh Vyas, Sylvie Freeman, Nigel H. Russell, Alan K. Burnett, David Grimwade - New England Journal of Medicine 2016 cited by 836

  3. Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials

    Authors: Rosie Bradley, Jeremy Braybrooke, Richard Gray, Robert K Hills, Zulian Liu, Hongchao Pan, Richard Peto, David Dodwell, Paul McGale, Carolyn Taylor, Prudence A Francis, Michael Gnant, Francesco Perrone, Meredith M Regan, Richard Berry, Clare Boddington, Mike Clarke, Christina Davies, Lucy Davies, Fran Duane, Vaughan Evans, Jo Gay, Lucy Gettins, Jon Godwin, Sam James, Hui Liu, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Simon Read, Ewan Straiton, Raimund Jakesz, Christian Fesl, Olivia Pagani, Richard Gelber, Michelino De Laurentiis, Sabino De Placido, Ciro Gallo, Kathy Albain, Stewart Anderson, Rodrigo Arriagada, John Bartlett, Elizabeth Bergsten-Nordström, Judith Bliss, Etienne Brain, Lisa Carey, Robert Coleman, Jack Cuzick, Nancy Davidson, Lucia Del Mastro, Angelo Di Leo, James Dignam, Mitch Dowsett, Bent Ejlertsen, Matthew Goetz, Pam Goodwin, Pat Halpin-Murphy, Dan Hayes, Catherine Hill, Reshma Jagsi, Wolfgang Janni, Sibylle Loibl, Eleftherios P Mamounas, Miguel Martín, Hirofumi Mukai, Valentina Nekljudova, Larry Norton, Yasuo Ohashi, Lori Pierce, Philip Poortmans, Kathleen I Pritchard, Vinod Raina, Daniel Rea, John Robertson, Emiel Rutgers, Tanja Spanic, Joseph Sparano, Guenther Steger, Gong Tang, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Xiang Wang, Tim Whelan, Nicholas Wilcken, Norman Wolmark, David Cameron, Jonas Bergh, Sandra M Swain - The Lancet Oncology 2022 cited by 299

  4. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials

    Authors: David Grimwade, Robert K. Hills, Anthony V. Moorman, Helen M. Walker, S Chatters, Anthony H. Goldstone, Keith Wheatley, Christine J. Harrison, Alan K. Burnett - Blood 2010 cited by 1,951

  5. openalex_id:w4226348827

    Authors: Rosie Bradley, Jeremy Braybrooke, Richard Gray, Robert K. Hills, Zulian Liu, Hongchao Pan, Richárd Pető, David Dodwell, Paul McGale, Carolyn Taylor, Prudence A. Francis, Michael Gnant, Francesco Perrone, Meredith M. Regan, Richard Berry, Clare Boddington, Mike Clarke, Christina Davies, Lucy Davies, Frances Duane, Vaughan Evans, Jo Gay, Lucy Gettins, Jon Godwin, Sam James, Hui Liu, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Simon Read, Ewan Straiton, R. Jakesz, Christian Fesl, Olivia Pagani, Richard D. Gelber, Michelino De Laurentiis, Sabino De Placido, Ciro Gallo, Kathy S. Albain, Stewart Anderson, R. Arriagada, John M.S. Bartlett, Elizabeth Bergsten-Nordström, Judith M. Bliss, Étienne Brain, Lisa A. Carey, Robert E. Coleman, Jack Cuzick, Nancy Davidson, Lucia Del Mastro, Angelo Di Leo, James Dignam, Mitch Dowsett, Bent Ejlertsen, Matthew Goetz, Pam Goodwin, Pat Halpin-murphy, Dan Hayes, Catherine Hill, Reshma Jagsi, Wolfgang Janni, Sibylle Loibl, Eleftherios P Mamounas, Miguel Martín, Hirofumi Mukai, Valentina Nekljudova, Larry Norton, Yasuo Ohashi, Lori Pierce, Philip Poortmans, Kathleen I Pritchard, Vinod Raina, Daniel Rea, John Robertson, Emiel Rutgers, Tanja Spanic, Joseph Sparano, Guenther Steger, Gong Tang, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Xiang Wang, Tim Whelan, Nicholas Wilcken, Norman Wolmark, David Cameron, Jonas Bergh, Sandra M Swain cited by 223

  6. Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials

    Authors: Rosie Bradley, Jeremy Braybrooke, Richard J. Gray, Robert K. Hills, Zulian Liu, Richárd Pető, Lucy Davies, David Dodwell, Paul McGale, Hongchao Pan, Carolyn Taylor, Stewart Anderson, Richard D. Gelber, Luca Gianni, William Jacot, Heikki Joensuu, Alvaro Moreno‐Aspitia, Martine Piccart, Michael F. Press, Edward H. Romond, Dennis J. Slamon, Vera J. Suman, Richard Berry, Clare Boddington, Mike Clarke, Christina Davies, Frances Duane, Vaughan Evans, Jo Gay, Lucy Gettins, Jon Godwin, Sam James, Hui Liu, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Simon Read, Ewan Straiton, Yaochen Wang, John Crown, Evandro de Azambuja, Suzette Delaloge, Helena Fung, Charles E. Geyer, M. Spielmann, Pinuccia Valagussa, Kathy S. Albain, Stewart Anderson, R. Arriagada, John Bartlett, Elizabeth Bergsten-Nordström, Judith M. Bliss, Étienne Brain, Lisa Carey, Robert E. Coleman, Jack Cuzick, Nancy E. Davidson, Lucia Del Mastro, Angelo Di Leo, James J. Dignam, Mitch Dowsett, Bent Ejlertsen, Prue Francis, Michael Gnant, Matthew Bidwell Goetz, Pam Goodwin, Pat Halpin-Murphy, Daniel Hayes, Catherine Hill, Reshma Jagsi, Wolfgang Janni, Sibylle Loibl, Eleftherios P. Mamounas, Miguel Martín, Hirofumi Mukai, Valentina Nekljudova, Larry Norton, Yasuo Ohashi, Lori J. Pierce, Philip Poortmans, Vinod Raina, Daniel Rea, Meredith M. Regan, J.F.R. Robertson, Emiel J. Rutgers, Tanja Španić, Joseph A. Sparano, Guenther G. Steger, Gong Tang, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Xiang Wang, Timothy J. Whelan, Nicholas Wilcken, Norman Wolmark, David Cameron, Jonas Bergh, Kathleen I. Pritchard and 1 more - The Lancet Oncology 2021 cited by 348

  7. Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials

    Authors: Jeremy Braybrooke, Rosie Bradley, Richard Gray, Robert K. Hills, Hongchao Pan, Richárd Pető, David Dodwell, Paul McGale, Carolyn Taylor, Tomohiko Aihara, Stewart Anderson, Joanne L. Blum, Fátima Cardoso, Xiaosong Chen, John Crown, Bent Ejlertsen, Thomas W. P. Friedl, Nadia Harbeck, Wolfgang Janni, Maj‐Britt Jensen, E. Mamounas, Kazutaka Narui, Ulrike Nitz, Larry Norton, Joyce O’Shaughnessy, Martine Piccart, Nicholas J. Robert, Zhi‐Ming Shao, Dennis Slamon, Joseph A. Sparano, Toru Watanabe, Greg Yothers, Ke‐Da Yu, Richard Berry, Clare Boddington, Mike Clarke, Christina Davies, Lucy Davies, Frances Duane, Vaughan Evans, Jo Gay, Lucy Gettins, Jon Godwin, Sam James, Hui Lui, Zulian Lui, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Simon Read, Ewan Straiton, Aman U. Buzdar, Vera J. Suman, Kelly K. Hunt, Robert Leonard, Janine Mansi, Catherine Delbaldo, Pascal Piedbois, Emmanuel Quinaux, Christian Fesl, Michael Gnant, Lidija Sölkner, Guenther G. Steger, Hans Petter Eikesdal, Per Eystein Lønning, Valerie Bée, Helena Fung, John R. Mackey, Miguel Martín, Michael F. Press, Evandro de Azambuja, Richard D. Gelber, Meredith M. Regan, Angelo Di Leo, Veerle Van Dooren, J.-M. Nogaret, John M.S. Bartlett, Bingshu E. Chen, Karen A. Gelmon, Paul E. Goss, Mark N. Levine, Wendy R. Parulekar, Kathleen I. Pritchard, Lois E. Shepherd, Donald A. Berry, Constance Cirrincione, Lawrence N. Shulman, Eric P. Winer, Rebecca Gelman, Jay R. Harris, Craig Henderson, Charles L. Shapiro, Peer Christiansen, Marianne Ewertz, Henning T. Mouridsen, Elise Van Leeuwen, Sabine C. Linn, Annelot G.J. van Rossum, Harm van Tinteren and 136 more - The Lancet 2023 cited by 189

  8. Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials

    Authors: Richard J. Gray, Rosie Bradley, Jeremy Braybrooke, Zulian Liu, Richárd Pető, Lucy Davies, David Dodwell, Paul McGale, Hongchao Pan, Carolyn Taylor, William E. Barlow, Judith M. Bliss, Paolo Bruzzi, David Cameron, George Fountzilas, Sibylle Loibl, John R. Mackey, Miguel Martín, Lucia Del Mastro, Volker Möbus, Valentina Nekljudova, Sabino De Placido, Sandra M. Swain, Michael Untch, Kathleen I. Pritchard, Jonas Bergh, Larry Norton, Clare Boddington, Julie Ann Burrett, Mike Clarke, Christina Davies, Frances Duane, Vaughan Evans, Lucy Gettins, Jon Godwin, Robert K. Hills, Sam James, Hui Liu, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Simon Read, Yaochen Wang, Zhe Wang, Peter A. Fasching, Nadia Harbeck, Pascal Piedbois, Michael Gnant, Guenther G. Steger, Angelo Di Leo, Stella Dolci, Prue Francis, Denis Larsimont, J.-M. Nogaret, C. Philippson, Martine Piccart, Sabine C. Linn, Petronella G.M. Peer, Vivianne C. G. Tjan‐Heijnen, S.B. Vliek, John R. Mackey, Dennis Slamon, John M.S. Bartlett, Vivien Bramwell, Bingshu E. Chen, Stephen Chia, Karen A. Gelmon, Paul E. Goss, Mark N. Levine, Wendy R. Parulekar, Joseph L. Pater, Eileen Rakovitch, Lois E. Shepherd, Dongsheng Tu, Timothy J. Whelan, Donald A. Berry, Gloria Broadwater, Constance Cirrincione, Hyman B. Muss, Raymond L. Weiss, Yi Shan, Yong fu Shao, Xiang Wang, Binghe Xu, Dongbing Zhao, Harry Bartelink, Nina Bijker, Jan Bogaerts, Fátima Cardoso, Tanja Čufer, Jean‐Pierre Julien, Philip Poortmans, Emiel J. Rutgers, Cornelis J.�H. van de Velde, Eva Carrasco, Miguel Ángel Seguí, Jens‐Uwe Blohmer, Serban Dan Costa, Bernd Gerber and 67 more - The Lancet 2019 cited by 394

  9. Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14 324 women in 16 trials

    Authors: Carolyn Taylor, David Dodwell, Paul McGale, Robert K. Hills, Richard Berry, Rosie Bradley, Jeremy Braybrooke, Mike Clarke, Richard Gray, Francesca Holt, Zulian Liu, Hongchao Pan, Richárd Pető, Ewan Straiton, Charlotte E. Coles, Frances Duane, Christophe Hennequin, Glenn Jones, Thorsten Kühn, Sileida Oliveros, Jens Overgaard, K.I. Pritchard, Chang‐Ok Suh, Graham Beake, Clare Boddington, Christina Davies, Lucy Davies, Vaughan Evans, Jo Gay, Lucy Gettins, Jon Godwin, Sam James, Amanda Kerr, Hui Liu, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Mariko Nakahara, Simon Read, Hannah Taylor, John Ferguson, H Scheurlen, Stefano Zurrida, Viviana Galimberti, James N. Ingle, Pinuccia Valagussa, Umberto Veronesi, Stewart Anderson, Gong Tang, Bernard Fisher, Sophie D. Fosså, Kristin V. Reinertsen, Herman Høst, Hyman B. Muss, Kaija Holli, Kathy S. Albain, R. Arriagada, John M.S. Bartlett, Elizabeth Bergsten-Nordström, Judith M. Bliss, Étienne Brain, Lisa A. Carey, Robert E. Coleman, Jack Cuzick, Nancy E. Davidson, Lucia Del Mastro, Angelo Di Leo, James J. Dignam, Mitch Dowsett, Bent Ejlertsen, Prue Francis, José Á. García-Sáenz, Rich Gelber, Michael Gnant, Matthew P. Goetz, Pam Goodwin, Pat Halpin-Murphy, Dan Hayes, Catherine Hill, Reshma Jagsi, Wolfgang Janni, Sibylle Loibl, Eleftherios P. Mamounas, Miguel Martín, Stuart McIntosh, Hirofumi Mukai, Valentina Nekljudova, Larry Norton, Yasuo Ohashi, Martine Piccart, Lori J. Pierce, Vinod Raina, Daniel Rea, Meredith M. Regan, J.F.R. Robertson, Emiel J. Rutgers, Roberto Salgado, Dennis J. Slamon, Tanja Španić and 14 more - The Lancet 2023 cited by 151

  10. Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials

    Authors: Robert K. Hills, Sylvie Castaigné, Frederick R. Appelbaum, Jacques Delaunay, Stephen H. Petersdorf, Megan Othus, Elihu H. Estey, Hervé Dombret, Sylvie Chevret, Norbert Ifrah, Jean‐Yves Cahn, Christian Récher, Lucy Chilton, Anthony V. Moorman, Alan K. Burnett - The Lancet Oncology 2014 cited by 698

  11. Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease

    Authors: Robert Howard, Rupert McShane, James Lindesay, Craig Ritchie, Ashley Baldwin, Robert Barber, Alistair Burns, Tom Dening, David M. Findlay, Clive Holmes, Alan Hughes, Robin Jacoby, Rob Jones, Roy Jones, Ian G. McKeith, Ajay Macharouthu, John T. O’Brien, Peter Passmore, Bart Sheehan, Edmund Juszczak, Cornelius Katona, Robert K. Hills, Martín Knapp, Clive Ballard, Richard G. Brown, Sube Banerjee, Caroline Onions, Mary Griffin, Jessica Adams, Richard Gray, Tony Johnson, Peter Bentham, Patrick Phillips - New England Journal of Medicine 2012 cited by 766

  12. Unified classification and risk-stratification in Acute Myeloid Leukemia

    Authors: Yanis Tazi, Juan E. Arango‐Ossa, Yangyu Zhou, Elsa Bernard, Ian Thomas, Amanda Gilkes, Sylvie Freeman, Yoann Pradat, Sean Johnson, Robert K. Hills, Richard Dillon, Max F. Levine, Daniel Leongamornlert, Adam P. Butler, Arnold Ganser, Lars Bullinger, Konstanze Döhner, Oliver G. Ottmann, Richard Adams, Hartmut Döhner, Peter J. Campbell, Alan K. Burnett, Michael Dennis, Nigel H. Russell, Sean M. Devlin, Brian J.P. Huntly, Elli Papaemmanuil - Nature Communications 2022 cited by 175

  13. Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial

    Authors: Alan K. Burnett, Nigel H. Russell, Robert K. Hills, David Bowen, Jonathan Kell, Steven Knapper, Yvonne G Morgan, Jennie Lok, Angela Grech, Gail Jones, Asim Khwaja, Lone S. Friis, Mary Frances McMullin, Ann Hunter, Richard E Clark, David Grimwade - The Lancet Oncology 2015 cited by 543

  14. Molecular MRD status and outcome after transplantation in NPM1-mutated AML

    Authors: Richard Dillon, Robert K. Hills, Sylvie Freeman, Nicola Potter, Jelena Jovanović, Adam Ivey, Anju Kanda, Manohursingh Runglall, Nicola Foot, Mikel Valgañón, Asim Khwaja, Jamie Cavenagh, Matthew L. Smith, Hans Beier Ommen, Ulrik Malthe Overgaard, Mike Dennis, Steven Knapper, Harpreet Kaur, David Taussig, Priyanka Mehta, Kavita Raj, Igor Novitzky‐Basso, Emmanouil Nikolousis, Robert Danby, Pramila Krishnamurthy, Kate Hill, Damian Finnegan, Samah Alimam, Erin Hurst, Peter Johnson, Anjum Khan, Rahuman Salim, Charles Craddock, Ruth Spearing, Amanda Gilkes, Rosemary E. Gale, Alan K. Burnett, Nigel H. Russell, David Grimwade - Blood 2020 cited by 166

  15. Minimal residual disease monitoring by quantitative RT-PCR in core binding factor AML allows risk stratification and predicts relapse: results of the United Kingdom MRC AML-15 trial

    Authors: John A. Liu Yin, Michelle A. O'Brien, Robert K. Hills, Sarah B. Daly, Keith Wheatley, Alan K. Burnett - Blood 2012 cited by 419

  16. Measurable Residual Disease at Induction Redefines Partial Response in Acute Myeloid Leukemia and Stratifies Outcomes in Patients at Standard Risk Without NPM1 Mutations

    Authors: Sylvie Freeman, Robert K. Hills, Paul Virgo, Naeem Khan, Steve Couzens, Richard Dillon, Amanda Gilkes, Laura Upton, Ove Juul Nielsen, James D. Cavenagh, Gail Jones, Asim Khwaja, Paul Cahalin, Ian Thomas, David Grimwade, Alan K. Burnett, Nigel H. Russell - Journal of Clinical Oncology 2018 cited by 200

  17. EZH2 mutations are frequent and represent an early event in follicular lymphoma

    Authors: Csaba Bödör, Vera Großmann, N.P. Popov, Jessica Okosun, Ciarán Ó’Riain, King Tan, Jacek Marzec, Shamzah Araf, Jun Wang, Abigail M. Lee, Andrew Clear, Silvia Montoto, Janet Matthews, Sameena Iqbal, Hajnalka Rajnai, Andreas Rosenwald, German Ott, Elı́as Campo, Lisa M. Rimsza, Erlend B. Smeland, Wing C. Chan, Rita M. Braziel, Louis M. Staudt, George W. Wright, T. Andrew Lister, Olivier Elemento, Robert K. Hills, John G. Gribben, Claude Chelala, András Matolcsy, Alexander Kohlmann, Torsten Haferlach, Randy D. Gascoyne, Jude Fitzgibbon - Blood 2013 cited by 323

  18. Optimization of Chemotherapy for Younger Patients With Acute Myeloid Leukemia: Results of the Medical Research Council AML15 Trial

    Authors: Alan K. Burnett, Nigel H. Russell, Robert K. Hills, Ann E. Hunter, Lars Kjeldsen, John Liu Yin, Brenda Gibson, Keith Wheatley, Donald Milligan - Journal of Clinical Oncology 2013 cited by 415

  19. Association between premature mortality and hypopituitarism

    Authors: Jeremy Tomlinson, N Holden, Robert K. Hills, Keith Wheatley, RN Clayton, AS Bates, MC Sheppard, PM Stewart - The Lancet 2001 cited by 1,009

  20. Overproduction of NOX-derived ROS in AML promotes proliferation and is associated with defective oxidative stress signaling

    Authors: Paul S. Hole, Joanna Zabkiewicz, Chinmay Munje, Zarabeth Newton, Lorna Pearn, P. Bruce White, Nuria Ponce Márquez, Robert K. Hills, Alan K. Burnett, Alex Tonks, Richard L. Darley - Blood 2013 cited by 230

  21. Low-Dose Cyclophosphamide Induces Antitumor T-Cell Responses, which Associate with Survival in Metastatic Colorectal Cancer

    Authors: Martin Scurr, Tom Pembroke, Anja Bloom, David C. S. Roberts, Amanda Thomson, Kathryn Smart, Hayley Bridgeman, Richard Adams, A. Brewster, Robert H. Jones, Sarah Gwynne, Daniel G. Blount, Richard Harrop, Robert K. Hills, Awen Gallimore, Andrew Godkin - Clinical Cancer Research 2017 cited by 164

  22. A randomized comparison of daunorubicin 90 mg/m2 vs 60 mg/m2 in AML induction: results from the UK NCRI AML17 trial in 1206 patients

    Authors: Alan K. Burnett, Nigel H. Russell, Robert K. Hills, Jonathan Kell, Jamie Cavenagh, Lars Kjeldsen, Mary‐Frances McMullin, Paul Cahalin, Mike Dennis, Lone Smidstrup Friis, Ian F. Thomas, Don Milligan, Richard E. Clark - Blood 2015 cited by 295

  23. Identification of Patients With Acute Myeloblastic Leukemia Who Benefit From the Addition of Gemtuzumab Ozogamicin: Results of the MRC AML15 Trial

    Authors: Alan K. Burnett, Robert K. Hills, Donald Milligan, Lars Kjeldsen, Jonathan Kell, Nigel H. Russell, John A. Liu Yin, Ann Hunter, Anthony H. Goldstone, Keith Wheatley - Journal of Clinical Oncology 2010 cited by 652

  24. The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia

    Authors: Rosemary E. Gale, Claire Green, Christopher Allen, Adam J. Mead, Alan K. Burnett, Robert K. Hills, David C. Linch - Blood 2007 cited by 744